Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
11.17
-0.09 (-0.80%)
At close: May 30, 2025, 4:00 PM
11.15
-0.02 (-0.18%)
After-hours: May 30, 2025, 4:02 PM EDT
Anika Therapeutics Stock Forecast
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for Anika Therapeutics stock ranges from a low of $19 to a high of $24. The average analyst price target of $21.5 forecasts a 92.48% increase in the stock price over the next year.
Price Target: $21.50 (+92.48%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Anika Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy Maintains $20 → $19 | Buy | Maintains | $20 → $19 | +70.10% | May 12, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $25 → $20 | Buy | Maintains | $25 → $20 | +79.05% | Mar 13, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $37 → $25 | Buy | Maintains | $37 → $25 | +123.81% | Nov 1, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $37 | Buy | Maintains | $37 | +231.24% | Oct 22, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $37 | Buy | Maintains | $37 | +231.24% | Aug 9, 2024 |
Financial Forecast
Revenue This Year
112.16M
from 119.91M
Decreased by -6.46%
Revenue Next Year
123.04M
from 112.16M
Increased by 9.70%
EPS This Year
-0.86
from -3.83
EPS Next Year
-0.08
from -0.86
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 116.0M | 128.6M | 132.8M |
| Avg | 112.2M | 123.0M | 129.0M |
| Low | 107.0M | 114.8M | 123.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -3.2% | 14.7% | 7.9% |
| Avg | -6.5% | 9.7% | 4.8% |
| Low | -10.7% | 2.3% | 0.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.47 | 0.81 | -0.29 |
| Avg | -0.86 | -0.08 | -0.29 |
| Low | -1.05 | -0.60 | -0.27 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.